Insider Trading disclosures for Coya Therapeutics Inc

The latest disclosure was made by Anabella Villalobos in Coya Therapeutics Inc where a trade of 5,000 Stock Option (right to buy) done was reported to US exchanges on Feb. 25, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Anabella Villalobos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2025	5,000	5,000	-		-	Stock Option (right to buy)
Ann Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2025	5,000	5,000	-		-	Stock Option (right to buy)
Dieter Weinand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2025	5,000	5,000	-		-	Stock Option (right to buy)
Wilbur L. Ross	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2025	5,000	5,000	-		-	Stock Option (right to buy)
Dov A. Goldstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2025	5,000	5,000	-		-	Stock Option (right to buy)
Howard Berman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2025	150,602	150,602	-		-	Stock Option (right to buy)
Arun Swaminathan	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2025	240,964	240,964	-		-	Stock Option (right to buy)
Fred Grossman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2025	140,562	140,562	-		-	Stock Option (right to buy)
David S. Snyder	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2025	140,562	140,562	-		-	Stock Option (right to buy)
Ann Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Dov A. Goldstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Wilbur L. Ross	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Dieter Weinand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Anabella Villalobos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
David S. Snyder	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 7.19 per share.	14 Nov 2024	1,800	8,800	-	7.2	12,934	Common Stock, par value $0.0001 per share
Arun Swaminathan	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 7.36 per share.	13 Nov 2024	5,000	10,000	-	7.4	36,797	Common Stock, par value $0.0001 per share
Arun Swaminathan	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 7.34 per share.	11 Nov 2024	5,000	5,000	-	7.3	36,689	Common Stock, par value $0.0001 per share
Fred Grossman	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 7.37 per share.	11 Nov 2024	2,710	2,710	-	7.4	19,973	Common Stock, par value $0.0001 per share
Howard Berman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2024	163,663	163,663	-		-	Stock Option (right to buy)
Fred Grossman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2024	70,596	70,596	-		-	Stock Option (right to buy)
David S. Snyder	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jun 2024	70,596	70,596	-		-	Stock Option (right to buy)
Snyder David S.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2024	81,819	81,819	-		-	Stock Option (right to buy)
Fred Grossman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	74,069	74,069	-		-	Stock Option (right to buy)
Grossman Fred	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	81,819	81,819	-		-	Stock Option (right to buy)
Berman Howard	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2024	189,680	189,680	-		-	Stock Option (right to buy)
Ross Wilbur L.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	10,000	10,000	-		-	Stock Option (right to buy)
Villalobos Anabella	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	5,000	5,000	-		-	Stock Option (right to buy)
Ann Lee	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	5,000	5,000	-		-	Stock Option (right to buy)
Garren Hideki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	5,000	5,000	-		-	Stock Option (right to buy)
Dieter Weinand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	5,000	5,000	-		-	Stock Option (right to buy)
A. Dov Goldstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Jan 2024	5,000	5,000	-		-	Stock Option (right to buy)
Ann Lee	Director	Purchase of securities on an exchange or from another person at price $ 3.62 per share.	22 Aug 2023	1,000	17,479	-	3.6	3,620	Common Stock, par value $0.0001 per share
Dieter Weinand	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Aug 2023	10,000	10,000	-		-	Stock Option (right to buy)
Fred Grossman	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jul 2023	74,069	74,069	-		-	Stock Option (right to buy)
Adrian Hepner	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2023	115,000	115,000	-		-	Stock Option (right to buy)
David S. Snyder	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2023	115,000	115,000	-		-	Stock Option (right to buy)
Howard Berman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Feb 2023	165,000	165,000	-		-	Stock Option (right to buy)
Hideki Garren	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	1,000	1,000	-		-	Warrant to Purchase Common Stock
Dov A. Goldstein	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	5,000	5,000	-		-	Warrant to Purchase Common Stock
Dov A. Goldstein	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	10,000	10,000	-		-	Common Stock, par value $0.0001 per share
Adrian Hepner	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	10,000	10,000	-		-	Common Stock, par value $0.0001 per share
Adrian Hepner	Chief Medical Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	5,000	5,000	-		-	Warrant to Purchase Common Stock
David S. Snyder	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	7,000	7,000	-		-	Common Stock, par value $0.0001 per share
David S. Snyder	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	3,500	3,500	-		-	Warrant to Purchase Common Stock
Hideki Garren	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	2,000	2,000	-		-	Common Stock, par value $0.0001 per share
Anabella Villalobos	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	5,000	5,000	-		-	Warrant to Purchase Common Stock
Anabella Villalobos	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2023	10,000	10,000	-		-	Common Stock, par value $0.0001 per share
Ann Lee	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2022	10,000	10,000	-		-	Common Stock, par value $0.0001 per share
Ann Lee	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jan 2022	5,000	9,479	-		-	Warrant to Purchase Common Stock
Ann Lee	Director		03 Jan 2022	6,479	16,479	-	4	25,916	Common Stock, par value $0.0001 per share

Showing 1 to 50 of 50 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

34.08% Fall from 52W High

Insider Trading disclosures for Coya Therapeutics Inc

The latest disclosure was made by Anabella Villalobos in Coya Therapeutics Inc where a trade of 5,000 Stock Option (right to buy) done was reported to US exchanges on Feb. 25, 2025.

Screeners based on Insider Trading and SAST parameters